Topic: Opioids
On June 30, several major pharmacy chains, including CVS Health Corp., Walmart Inc., Rite-Aid Corp. and Walgreen Co. asked the Sixth Circuit to disqualify the judge overseeing the sprawling opioid litigation, Ohio U.S. District Judge Dan Aaron Polster, accusing him of bias. In April, Judge Polster scheduled a new bellwether trial shortly after issues involving […]
On April 15, the U.S. Court of Appeals for the Sixth Circuit unanimously granted the writ of mandamus filed by several major pharmacy chains, finding that U.S. District Judge Dan Polster of the Northern District of Ohio, who is presiding over the 2,600 case MDL, improperly allowed dispensing allegations to be added to the complaints […]
The trial in the lawsuit filed by New York State Attorney General Letitia James against a number of major drug companies including Endo Pharmaceuticals, Teva Pharmaceuticals, Allergan Inc., McKesson Corp., Cardinal Health Inc., AmerisourceBergen Drug Corp., Rochester Drug Cooperative Inc. and divisions of Johnson & Johnson has been postponed indefinitely due to the ongoing Coronavirus […]
State and local governments in West Virginia are poised to put an end to most of the ongoing litigation stemming from the decades-long opioid crisis that has been linked to over 430,000 deaths across the country since 2000. The $1.25 billion deal was crafted in Charleston last week between 250 attorneys and companies from all […]
A proposed settlement has been reached with generic drug manufacturer Mallinckrodt Pharmaceuticals, in which the company will pay $1.6 billion to settle thousands of lawsuits filed in the Cleveland MDL as well as by 47 state and U.S. territory attorneys general as part of their role in the rampant opioid crisis. The settlement will put […]
On Friday, February 7, arguments were underway in the 6th Circuit Court of Appeals as drug distributors and municipalities sought to overturn a federal district judge’s certification of a ”negotiation class” tasked with achieving a global settlement between the pharmaceutical companies and the 30,000 cities and counties in the United States affected by the widespread […]
Late last month Johnson & Johnson announced a voluntary recall of approximately 33,000 bottles of its baby powder after the FDA reported finding chrysotile asbestos in the product. While J&J maintains that “thousands of tests over the past 40 years repeatedly confirm that our consumer talc products do not contain asbestos”, it appears that the […]
In an effort to avert the landmark federal opioid trial brought by two Ohio counties and scheduled to begin on October 21, four key defendants reached a last minute $260 million settlement. Distributors Amerisource Bergen, Cardinal Health, McKesson and drug manufacturer Teva Pharmaceutical joined other defendants including Johnson & Johnson, Janssen, Mallinckrodt, Endo International, and […]
On Friday, September 27, a woman suffering from mesothelioma, a cancer linked to asbestos exposure, and her husband were awarded $40.3 million by a California jury. Nancy Cabibi, 71, was a regular user of Johnson’s Baby Powder and Shower To Shower talc products, both of which are manufactured by J&J; according to documents filed with […]
The first hearing in Purdue Pharma’s Chapter 11 bankruptcy filing was held on Tuesday September 17 before U.S. Bankruptcy Judge Robert Drain in White Plains, NY, two days after the drug maker filed for bankruptcy and just weeks before the first trial is scheduled to be held in the consolidated multidistrict opiate litigation in Cleveland, […]
